540P Early treatment discontinuation (ETD) in dMMR/MSI-H metastastic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICIs).

Autor: Taieb, J.1 (AUTHOR), Ambrosini, M.1 (AUTHOR), Alouani, E.L.2 (AUTHOR), Lonardi, S.3 (AUTHOR), Sinicrope, F.A.4 (AUTHOR), Decraecker, M.5 (AUTHOR), Hollebecque, A.6 (AUTHOR), Hafliger, E.1 (AUTHOR), Mazard, T.7 (AUTHOR), Pernot, S.8 (AUTHOR), Parent, P.9 (AUTHOR), Fernandez, M.E. Elez10 (AUTHOR), Overman, M.J.11 (AUTHOR), Jayachandran, P.12 (AUTHOR), Nasca, V.13 (AUTHOR), Salvatore, L.14 (AUTHOR), Guimbaud, R.15 (AUTHOR), Cremolini, C.16 (AUTHOR), Tougeron, D.17 (AUTHOR), Pietrantonio, F.13 (AUTHOR)
Zdroj: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS450-S451. 2p.
Databáze: Academic Search Ultimate